主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRVO
#3585
CervoMed Inc. Common Stock
3.9
9
-5.00%
版块:
基础:
利润货币:
日范围
年范围
日变化
-5.00%
每月变动
-31.91%
6个月变化
-58.13%
年变化
+83.87%
前一天收盘价
4.2
0
Open
3.9
9
Bid
Ask
Low
3.9
9
High
3.9
9
交易量
6
市场
股票
医疗保健
CRVO
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
8.25 M
8.7 M
8.7 M
9.25 M
9.25 M
—
Valuation ratios
Enterprise value
112.76 M
11.36 M
69.13 M
49.83 M
65.42 M
195.74 M
Price to earnings ratio
-6.92
-1.16
-4.14
-2.38
-2.76
-10.44
Price to sales ratio
7.62
1.94
8.4
6.93
11.25
28.51
Price to cash flow ratio
-7.32
-1.14
-4.06
-2.3
-2.82
-10.32
Price to book ratio
1.23
0.48
0.54
0.35
0.53
1.9
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.1
-0.16
-0.13
-0.16
-0.25
-0.7
Return on equity %
-0.1
-0.17
-0.14
-0.19
-0.3
-0.8
Return on invested capital %
—
—
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
-278.19
-334.91
-276.55
-376.41
-2 493.79
-3 481.67
EBITDA margin %
—
—
—
—
—
—
Net margin %
-245.06
-310.17
-255.23
-356.05
-2 395.34
-3 316.8
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
10.93
8.66
8.2
6.05
5
27.91
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.04
0.05
0.05
0.05
0.01
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.56
-1
-0.45
-0.73
-0.7
-2.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
5.36
1.11
4.05
3.74
2.95
11.86
Net current asset value per share
5.61
5.34
4.43
4.25
3.31
17.33
Tangible book value per share
5.24
4.86
3.98
3.74
2.81
15.38
Working capital per share
5.1
4.72
3.89
3.55
2.65
14.81
Book value per share
5.24
4.86
3.98
3.74
2.81
15.38
新闻
CervoMed的neflamapimod入选英国ALS试验平台
CervoMed’s neflamapimod selected for UK ALS trial platform
Cantor Fitzgerald 给予 CervoMed 股票"增持"评级
Cantor Fitzgerald initiates CervoMed stock with Overweight rating
CervoMed股价在有前景的痴呆症药物试验结果后飙升
CervoMed的路易体痴呆症药物在2b期临床试验中显示前景
CervoMed’s DLB drug shows promise in phase 2b trial
CervoMed stock soars after promising dementia drug trial results
Neflamapimod reduces key neurodegeneration markers in DLB study
CervoMed Inc.:首席商务官Winton购入价值4.143万美元CRVO股票
CervoMed首席执行官Alam购买价值182,736美元的股票
葛雷瓜尔·西尔维以182,736美元购入CervoMed (CRVO)股票